glycyrrhizic acid has been researched along with Chronic Hepatitis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanai, T; Komatsu, A; Nakamura, T; Suzuki, T; Watanabe, K; Yoshino, T | 1 |
| Jin, H; Ling, Q; Shi, G; Zheng, J | 1 |
| Koga, K; Ohyanagi, K; Takada, K; Tomoyama, M | 1 |
| Koga, K; Matsuno, K; Nishimon, Y; Takada, K; Ueta, H | 1 |
| Endo, Y; Funaki, N; Hashimoto, N; Hayashi, S; Hayashida, N; Ikeda, Y; Iwabuchi, S; Kako, M; Mitamura, K; Miyake, K; Miyazaki, J; Ota, Y; Sato, Y; Suzuki, H; Tanaka, K; Tango, T; Tomi, T; Umeda, T; Yoshiba, M | 1 |
| Kawashima, S; Koga, K; Shibata, N; Takada, K | 1 |
| Arai, K; Okuno, T; Shindo, M | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Koida, I; Kumada, H; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A | 1 |
| Aikawa, T; Iga, T; Kotaki, H; Sawada, Y; Tanaka, N; Yamamura, Y | 1 |
| Baltina, LA; Pokrovskił, AG; Shul'ts, EE; Tolstikov, GA | 1 |
| Zeuzem, S | 1 |
| Harada, K; Ishida, M; Ito, H; Katayama, S; Kawasaki, H; Okubo, M; Shiota, G; Tomie, Y | 1 |
| Shibata, S | 1 |
| Eisenburg, J | 1 |
| Hayashi, J; Hayashi, S; Hirata, M; Kajiyama, W; Kashiwagi, S; Nakashima, K; Noguchi, A | 1 |
| Kobayashi, M; Koike, M; Miyashiro, E; Sumiyama, K | 1 |
| Iwamura, K; Ohta, W | 1 |
| Yang, ZH; Zhang, ZH | 1 |
5 review(s) available for glycyrrhizic acid and Chronic Hepatitis
| Article | Year |
|---|---|
[A meta-analysis of diammonium glycyrrhizinate enteric-coated capsules versus diammonium glycyrrihizinate in patients with chronic viral hepatitis].
Topics: Capsules; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Randomized Controlled Trials as Topic | 2014 |
[Novel formulations of a liver protection drug glycyrrhizin].
Topics: Adjuvants, Pharmaceutic; Animals; Cell Membrane Permeability; Chemistry, Pharmaceutical; Dosage Forms; Drug Administration Routes; Drug Compounding; Glycyrrhizic Acid; Hepatitis, Chronic; Humans; Liver; Solubility | 2007 |
[Efficacy of interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy].
Topics: Adult; Aged; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Male; Middle Aged | 1994 |
[Glycyrrhizic acid].
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Carbenoxolone; Glucuronates; Glucuronic Acid; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis, Chronic; Humans; Rats | 1997 |
A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Chalcone; Chalcones; Cytotoxicity, Immunologic; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis, Chronic; Humans; Phytotherapy; Plants, Medicinal | 2000 |
3 trial(s) available for glycyrrhizic acid and Chronic Hepatitis
| Article | Year |
|---|---|
Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
Topics: Alanine Transaminase; Antiviral Agents; Female; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome | 2002 |
The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride-intoxicated rats.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspartate Aminotransferases; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Glycyrrhizic Acid; Hepatitis, Chronic; Humans; Infusions, Intravenous; Injections, Intravenous; Liver; Male; Rats; Rats, Wistar | 1997 |
[Treatment of chronic hepatitis B. Part 2: Effect of glycyrrhizic acid on the course of illness].
Topics: Adult; Aged; Antiviral Agents; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Male; Middle Aged | 1992 |
10 other study(ies) available for glycyrrhizic acid and Chronic Hepatitis
| Article | Year |
|---|---|
Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: A retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Bilirubin; Cohort Effect; Female; Glycyrrhizic Acid; Hepatitis, Chronic; Humans; Hypokalemia; Liddle Syndrome; Male; Middle Aged; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Pharmacokinetics of glycyrrhizin in normal and albumin-deficient rats.
Topics: Animals; Anti-Inflammatory Agents; Bile; Glycyrrhizic Acid; Hepatitis, Chronic; Infusions, Intravenous; Liver; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Serum Albumin | 2008 |
Utility of nano-sized, water-in-oil emulsion as a sustained release formulation of glycyrrhizin.
Topics: Animals; Bile; Delayed-Action Preparations; Emulsions; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis, Chronic; Liver; Male; Nanoparticles; Oils; Plant Extracts; Rats; Rats, Sprague-Dawley; Water | 2011 |
The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Cause of Death; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Hepatitis, Chronic; Humans; Japan; Liver Neoplasms; Long-Term Care; Male; Middle Aged; Regression Analysis; Retrospective Studies | 1997 |
[Glycyrrhizin for the treatment of allergic diseases and chronic hepatitis].
Topics: Anti-Allergic Agents; Antiviral Agents; Contraindications; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Hypersensitivity | 1998 |
Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Diethylnitrosamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Liver; Liver Function Tests; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Organ Size | 1999 |
Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.
Topics: Adult; Antiviral Agents; Drug Administration Schedule; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Interferon-alpha; Male | 1991 |
Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive).
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Infant; Injections, Intravenous; Male; Oleanolic Acid; Solutions; Time Factors; Transfer Factor | 1991 |
[Treatment of non-A, non-B hepatitis with glycyrrhizin].
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Drug Evaluation; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver; Male; Middle Aged | 1988 |
[Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
Topics: Adolescent; Adult; Antiviral Agents; Combined Modality Therapy; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis, Chronic; Humans; Male; Vidarabine | 1988 |